Research graph
References from Evaluation of clinical and laboratory findings in MIS-C patients associated with COVID-19: An experience from the Northwest of Iran. Local targets link to admitted publications; unresolved targets remain external evidence.
Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020
10.3346/jkms.2020.35.e112 · 2020 · External reference
A novel coronavirus from patients with pneumonia in China, 2019
10.1056/nejmoa2001017 · 2020 · External reference
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
10.1016/j.ijantimicag.2020.105924 · 2020 · External reference
Clinical features of patients infected with 2019 novel coronavirus in Wuhan
10.1016/s0140-6736(20)30183-5 · 2020 · External reference
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
2020 · External reference
Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review. Journal of Interferon &
2020 · External reference
Preliminary evidence on long COVID in children
10.1111/apa.15870 · 2021 · External reference
Hyperinflammatory shock in children during COVID-19 pandemic
10.1016/s0140-6736(20)31094-1 · 2020 · External reference
Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019
10.3345/cep.2020.01900 · 2021 · External reference
Hyperinflammatory syndrome in children associated with COVID-19: need for awareness
10.1007/s13312-020-1997-1 · 2020 · External reference
Multisystem inflammatory syndrome in US children and adolescents
10.1056/nejmoa2021680 · 2020 · External reference
COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis.
2021 · External reference
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.
10.1001/jama.2021.2091 · 2021 · External reference
Unresolved reference
2020 · External reference
The immunology of multisystem inflammatory syndrome in children with COVID-19
10.1016/j.cell.2020.09.016 · 2020 · External reference
Multisystem inflammatory syndrome in children: a systematic review.
10.1016/j.eclinm.2020.100527 · 2020 · External reference
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
10.1186/s13054-020-03332-4 · 2020 · External reference
Association between coagulation profile and clinical outcome in children with SARS-CoV-2 infection or MIS-C: A multicenter cross-sectional study.
10.3390/children9020279 · 2022 · External reference
Clinical and laboratory characteristics of multisystem inflammatory syndrome in children associated with COVID‐19 in Egypt: a tertiary care hospital experience
10.1111/jpc.16311 · 2023 · External reference
Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: A multicenter study.
10.1371/journal.pone.0274104 · 2022 · External reference
Clinical profile and outcomes of multisystem inflammatory syndrome in children (MIS‐C): Hospital‐based prospective observational study from a tertiary care hospital in South India.
10.1111/jpc.16129 · 2022 · External reference
Multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 and 1-year follow-up.
10.1007/s12098-022-04385-9 · 2023 · External reference
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.
2024 · External reference
Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus‐2 pandemic in Turkey: A single‐centre experience
10.1111/jpc.15674 · 2022 · External reference
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
10.1186/s13054-020-03332-4 · 2020 · External reference
COVID-19–associated multisystem inflammatory syndrome in children—United States, March–July 2020
2020 · External reference
COVID-19-associated multisystem inflammatory syndrome in children: a multicentric retrospective cohort study.
2021 · External reference
Distinct characteristics of multisystem inflammatory syndrome in children in Poland.
10.1038/s41598-021-02669-2 · 2021 · External reference
Incidence and Risk Factors of Hyperglycemia in Severe Multisystem Inflammatory Syndrome in Children: A Retrospective Case-Control Study
10.1055/s-0042-1758744 · 2023 · External reference
New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19.
10.1515/jpem-2020-0426 · 2021 · External reference
A Case of Severe MIS-C in Pediatric Diabetes: Complications of COVID-19.
10.1210/jendso/bvab048.1410 · 2021 · External reference
Multisystem inflammatory syndrome in children
10.1056/nejmoa2021756 · 2020 · External reference
Unresolved reference
2020 · External reference
Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.
10.1016/j.prrv.2020.08.001 · 2021 · External reference
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
10.1017/s095026882000196x · 2020 · External reference
A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection
10.1097/inf.0000000000002888 · 2020 · External reference
Clinical and laboratory characteristics of the multisystem inflammatory syndrome in children: a case series of 75 patients.
2022 · External reference
Multi-organ presentation of children with COVID-19 infection in the north of Iran: a retrospective study
2021 · External reference
Renal Involvement in Multisystem Inflammatory Syndrome in Children: Not Only Acute Kidney Injury.
10.3390/children10101661 · 2023 · External reference
Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data.
10.1371/journal.pone.0266737 · 2022 · External reference
Unresolved reference
2021 · External reference
Non-COVID infections causing MIS-C in COVID recovered children: An association or co-illness–A case series
10.4103/jfmpc.jfmpc_257_22 · 2022 · External reference
Inflammatory bowel disease presenting with concurrent COVID-19 multisystem inflammatory syndrome
10.1542/peds.2020-027763 · 2021 · External reference
Inflammatory markers in cardiovascular disease; lessons learned and future perspectives.
10.2174/1570161118666200318104434 · 2021 · External reference
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool
10.1186/s43044-020-00075-z · 2020 · External reference
Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
10.1001/jama.2020.10369 · 2020 · External reference
Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.
10.1016/j.ajem.2021.05.044 · 2021 · External reference
Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.
10.1016/j.cyto.2021.155478 · 2021 · External reference
Change in severity and clinical manifestation of MIS-C over SARS-CoV-2 variant outbreaks
2023 · External reference
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
10.1017/s0950268822001522 · 2022 · External reference
